Relevant bibliographies by topics / Asthma – Treatment

Academic literature on the topic 'Asthma – Treatment'

Author: Grafiati

Published: 4 June 2021

Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Asthma – Treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Asthma – Treatment"

Syabbalo, Nightingale. "Severe Neutrophilic Asthma: Pathogenesis and Treatment." Journal of Thoracic Disease and Cardiothoracic Surgery 3, no. 1 (January 15, 2022): 01–13. http://dx.doi.org/10.31579/2693-2156/030.

Full text

Abstract:

Asthma is a common chronic airway disease affecting about 358 million people worldwide, and an estimated 7 million children globally. Approximately 10% of patients with asthma have severe refractory disease, which is difficult to control on high doses of inhaled corticosteroids and other modifiers. Among these, are patients with severe neutrophilic asthma. Neutrophilic asthma is a severe phenotype of asthma, characterized by frequent exacerbations, persistent airway obstruction, and poor lung function. Immunopathologically, it is characterized by the presence of high levels of neutrophils in the airways and lungs. Interleukin-17 produced by Th17 cells, plays a key role in the pathogenesis of neutrophilic asthma by expressing the secretion of chemoattractant cytokines and chemokines for the recruitment, and activation of neutrophils. Interleukin-8 is a powerful chemoattractant and activator of neutrophils. Activated neutrophils produce an oxidative burst, releasing multiple reactive oxygen species, proteinases, cytokines, which cause airway epithelial cell injury, inflammation, airway hyperresponsiveness, and remodeling. Furthermore, exasperated neutrophils due to viral, bacterial or fungal infections, and chemical irritants can release extracellular nucleic acids (DNA), designated as NETs (neutrophil extracellular traps), which are more toxic to the airway epithelial cells, and orchestrate airway inflammation, and release alarmin cytokines. Dysregulated NETs formation is associated with severe asthma. Most patients with neutrophilic asthma are unresponsive to the standard of care, including high dose inhaled corticosteroids, and to targeted biologics, such as mepolizumab, and dupilumab, which are very effective in treating eosinophilic asthma. There is unmet need to explore for novel biologics for the treatment of neutrophilic asthma, and in refining therapies, such as bronchial thermoplasty.

APA, Harvard, Vancouver, ISO, and other styles

Syabbalo, Nightingale. "Aerosol Biologics for the Treatment of Eosinophilic Asthma." Journal of Thoracic Disease and Cardiothoracic Surgery 3, no. 1 (January 15, 2022): 01–05. http://dx.doi.org/10.31579/2693-2156/035.

Full text

Abstract:

Asthma is a heterogeneous chronic airway disease comprising of distinct phenotypes characterized by different immunopathophysiologic pathways, clinical features, disease severity, and response to treatment. The phenotypes of asthma include eosinophilic, neutrophilic, mixed cellularity, and paucigranulocytic asthma. Eosinophilic asthma is principally a T helper type 2 (Th2)-mediated airway disease. However, several other immune and structural cells secrete the cytokines implicated in the pathogenesis of eosinophilic asthma. Innate type 2 lymphoid cells, mast cells, basophils, and eosinophils secrete Th2 cytokines, such as interleukin-4 (IL-4), IL-13, and IL-5. Additionally, airway epithelial cells produce alarmin cytokines, including IL-25, IL-33, and thymic stromal lymphopoietin (TSLP). Alarmins are the key initiators of allergic inflammation at the sentinel mucosal surfaces. Innovative biotherapeutic research has led to the discovery of monoclonal antibodies which target and inhibit the immunopathological effects of the cytokines involved in the pathogenesis of eosinophilic asthma. Parenteral biologics targeting the inciting interleukins, include mepolizumab and reslizumab (anti-IL-5), benralizumab (anti-IL-5Rα), dupilumab (anti-4Rα), and tezelizumab (anti-TSLP). They have been shown to significantly reduce annualized exacerbation rates, improve asthma control, lung function, and quality of life. Currently, there are no pulmonary delivered aerosol biologics for topical treatment of asthma. CSJ117 is a potent neutralizing antibody Fab fragment against TSLP, formulated as a PulmoSol TM engineered powder, and is delivered to the lungs by a dry powder inhaler. Phase 2 placebo-controlled clinical trial evaluated the efficacy and safety of CSJ117. CSJ117 delivered as an inhaler attenuated the late asthmatic response (LAR), and the early asthmatic response (EAR) after allergen inhalation challenge (AIC) at day 84 of treatment. The maximum decrease in FVE1 from pre-AIC were significantly lower in the CSJ117 group compared to placebo (P = 029), during LAR. CSJ117 also significantly reduced fractional exhaled nitric oxide before AIC at day 83; and significantly reduced the allergen-induced increase in % sputum eosinophil count. Pulmonary delivery of biologics directly to the airway mucosal surface has several advantages over parenteral routes, particularly in treating airway diseases such as asthma. Inhaler delivered biologics, such as CSJ117 are innovative and attractive methods of future precision treatment of asthma, and other respiratory diseases.

APA, Harvard, Vancouver, ISO, and other styles

Syabbalo, Nightingale. "Biologics in the Treatment of Severe Uncontrolled Asthma in Children." Journal of Thoracic Disease and Cardiothoracic Surgery 2, no. 2 (August 11, 2021): 01–08. http://dx.doi.org/10.31579/2693-2156/024.

Full text

Abstract:

Asthma is the most common chronic disease in children, currently affecting about 7 million children. Severe uncontrolled asthma is rare in children with a prevalence of about 2.1% to 5%, but inflicts a disproportionate health burden. Children with severe asthma have increased risk of life threatening exacerbations, frequent hospitalization, worsening health-related quality of life, and impaired physical activity. Severe asthma in childhood is associated with long-term morbidities, such as bronchiolitis obliterans, impaired airway development, and development of chronic obstructive pulmonary disease in adulthood. Childhood asthma like adult-onset asthma, is classified into four cellular inflammatory phenotypes using induced sputum cytometry. The four phenotypes of asthma include eosinophilic asthma, neutrophilic asthma, paucigranulocytic asthma, and mixed cellularity asthma. The pathophysiological mechanisms of asthma involve airway inflammation and remodeling. Inflammatory mediators such as cytokines, chemokines, adhesion molecules, and growth factors play a key role in orchestration airway remodeling. During airway inflammation, cytokines secreted by type 2 helper (Th2) lymphocytes, such as interleukin-5 (IL-5), IL-4, IL-13, IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) play a key role in the pathogenesis of eosinophilic asthma. Whereas, the Th17 axis cytokines, including IL-17, IL-23, and IL-8 are responsible for the pathophysiology of neutrophilic asthma. The airway structural changes due to airway remodeling lead to thickening of the airway wall, narrowing of the bronchiolar lumen, airway obstruction, and decline in pulmonary function. Most of the children with asthma respond to low and medium inhaled corticosteroids, however a significant proportion still have severe asthma uncontrolled on the standard of care. The most common asthma phenotype in children is eosinophilic asthma, which responds superbly to biologic therapy. Children with severe asthma require add-on targeted interleukin antagonists (ILA), such as mepolizumab (anti-IL-5), benralizumab (anti-IL-5Rα), and dupilumab (anti-4Rα). ILAs have been shown to ameliorate asthma symptoms, reduce moderate and severe exacerbations, and improve pulmonary function. Additionally, ILAs have been demonstrated to improve the health-related quality of life, and have steroid sparing effect.

APA, Harvard, Vancouver, ISO, and other styles

Ivanova, N. A., E. I. Khubulava, N. A. Ivanova, and E. I. Hubulava. "Asthma treatment improvement." Russian Journal of Allergy 4, no. 3 (September 15, 2007): 58–62. http://dx.doi.org/10.36691/rja88.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Galant, Stanley P. "Treatment of asthma." Postgraduate Medicine 87, no. 4 (March 1990): 229–36. http://dx.doi.org/10.1080/00325481.1990.11704609.

Full text

APA, Harvard, Vancouver, ISO, and other styles

&NA;. "On asthma treatment." Inpharma Weekly &NA;, no. 740 (June 1990): 16. http://dx.doi.org/10.2165/00128413-199007400-00039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Damani, S. "Individualizing Asthma Treatment." Science Translational Medicine 3, no. 104 (October 12, 2011): 104ec164. http://dx.doi.org/10.1126/scitranslmed.3003281.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Ward, MichaelJ. "TREATMENT OF ASTHMA." Lancet 327, no. 8480 (March 1986): 559. http://dx.doi.org/10.1016/s0140-6736(86)90913-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Bradley, David. "Dramatic asthma treatment." Pharmaceutical Science & Technology Today 1, no. 7 (October 1998): 289–90. http://dx.doi.org/10.1016/s1461-5347(98)00080-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Chung, K. F., and P. J. Barnes. "Treatment of asthma." BMJ 294, no. 6564 (January 10, 1987): 103–5. http://dx.doi.org/10.1136/bmj.294.6564.103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Asthma – Treatment"

Hodgson, David Brian. "Investigating new treatment options for refractory asthma." Thesis, University of Nottingham, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664300.

Full text

Abstract:

Patients with difficult to manage asthma and chronic cough are commonly seen by respiratory physicians in the NHS. This thesis describes three randomised trials which explore new treatment options for these difficult groups. Non-invasive markers of airway inflammation and function were measured before each trial to help determine likely responders. In the first study, 30 patients with asthma and eosinophilic inflammation were given two weeks of prednisolone and then randomised to receive either ciclesonide 360mcg or placebo twice daily for 8 weeks. Though the between- group differences were not significant several patients had changed their usual maintenance dose of prednisolone during the trial. When these patients were removed from the analysis there was a significant improvement sputum eosinophils with ciclesonide. There was no significant change in the marker of small airway inflammation, so it is possible that this effect was due to a general reduction in airway inflammation from the higher dose of inhaled steroids, rather than specifically targeting the small airways. In the second study, 28 patients with refractory asthma were given azithromycin 250mg or placebo three times weekly for six weeks in a randomised, cross-over design. Though significant improvements in airway hyper-responsiveness, asthma control and sputum neutrophils were seen with azithromycin, these changes were not significant when compared to placebo.

APA, Harvard, Vancouver, ISO, and other styles

Khan, Md Sanaur Rahman School of Women?s &amp Children?s Health UNSW. "Improving the management of childhood asthma." Awarded by:University of New South Wales. School of Women?s and Children?s Health, 2003. http://handle.unsw.edu.au/1959.4/19256.

Full text

Abstract:

Objectives: To improve the management of childhood asthma. Subjects & Setting: Children admitted with asthma from 1st January 2000 to 31st December 2000; and children discharged with asthma from Emergency Department (ED) of Sydney Children?s Hospital (SCH) between 16th October 2000 and 28th February 2002. Methods: There were two major studies addressing aspects of asthma management, namely the retrospective in-patient study and the prospective ED presentation study. Each of these was subdivided in two different studies to address different research questions. In the first retrospective study, a priori criteria for theoretical "time ready for discharge" (TRD) for asthmatic admissions were defined based on frequency of use of salbutamol. In the second retrospective study, we followed 361 children for 1 year from the date of their discharge, to find out whether those who received asthma education, written asthma action plan, and preventer medications at the time of discharge and whose follow?up was arranged prior to discharge, represented to the ED or were readmitted. The prospective study, which also addressed two different research questions, was a randomised-controlled trial in which parents of 310 children who had been discharged from ED with asthma, received written asthma materials only or received telephone consultation in addition to written materials. Background severity and control of asthma were assessed in baseline study from parent?s reported symptom frequency and medication uses. Outcome measures: readmission and representation to the ED, regular use of preventer medications, possession and use of written asthma action plan, and asthma symptom measures. Results: (1) 116 (27.7%) children were discharged before our theoretical TRD and only 2 child who were discharged after achieving TRD, developed symptoms which required oxygenation and more frequent doses of salbutamol. Both readmission and representation to ED within one week of discharge were uncommon. (2) 121 children represented within 1 year of their discharge, of whom 68 children were readmitted. Both receiving asthma education during admission and arranging follow-up prior to discharge were associated with a decreased likelihood of representation as well as readmission (P > 0.001). (3) In RCT, the baseline study showed that 14% of children were not receiving appropriate preventer therapy despite indications; and a further 34% had frequent symptoms despite receiving preventer therapy. 62% of the parents reported of having written asthma action plan but less than 50% of them reported using it regularly. At follow up we observed both possession and use of written asthma action plan (p = 0.002) as well as regular use of preventer medications (p = 0.001) were improved in the intervention group compared with the control group. Conclusions: Discharge on 3-hourly rather than 4-hourly doses of salbutamol appears safe and shortens length of stay by an average of 5.5 hrs. Both asthma education and follow-up at the time discharge appear to reduce readmission and representation to ED. Telephone consultation can increase the regular use of preventer medications and written asthma action plan.

APA, Harvard, Vancouver, ISO, and other styles

Lau, Ming-wai, and 劉明偉. "Effectiveness of pharmacist interventions in the self management of asthma in the community setting : a systematic review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193784.

Full text

Abstract:

Background: Asthma is a global health problem affecting people of all ages. Despite huge progress on the management of asthma in recent decades, suboptimal health outcomes associated with under-management is still commonly encountered. Self management was shown to be a both clinically and cost effective approach to improve asthma outcomes in some studies. The role of pharmacists in promoting self management of asthma was explored in individual studies but limited review was conducted to assess its effectiveness. Objective: To investigate the effectiveness of pharmacist interventions on the self management of asthma patients in the community setting and to examine if the benefits, if any, could be realized by implementing such interventions in Hong Kong. Methods: A systematic search was conducted on Medline, Embase, Pubmed and Cochrane Library without time limit to identify studies assessing the clinical, humanistic and economic outcomes of pharmacist-led self management interventions towards adolescent or adult patients with asthma compared to usual care. Risk of bias of studies was appraised using a tool adapted from the Effective Practice of Organization of Care version of the Cochrane Risk of Bias Tool. Results: The search yielded 504 studies of which eight studies were eligible for inclusion. The included studies involved 1674 patients, were published between 2001 and 2008 and were originated from seven countries. Discrepancies of findings were noted in the majority of outcome measures reviewed. Significant benefits of pharmacist interventions included improvement of inhalation technique and reduction of rescue medication use although no significant effect was observed with regard to forced expiratory volume in one second and days lost from work or school. Conclusions: The evidence of pharmacist interventions on the self management of asthma remains inconsistent, probably attributable to variable quality of studies and heterogeneous assessment methods and outcome measures. Future research should aim to produce randomized, controlled studies incorporating allocation concealment with a follow-up period of over one year. Nevertheless, pharmacist-led asthma self management initiatives could be implemented at the general outpatient clinic setting in Hong Kong to further improve the quality of primary care.
published_or_final_version
Public Health
Master
Master of Public Health

APA, Harvard, Vancouver, ISO, and other styles

Ställberg, Björn. "Asthma in Primary Care : Severity, Treatment and Level of Control." Doctoral thesis, Uppsala universitet, Allmänmedicin och klinisk epidemiologi, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-9332.

Full text

Abstract:

Aims. The overall aim was to examine the severity, treatment and level of control in patients with asthma in primary care in Sweden. The specific aims were to assess what matters to asthma patients, evaluate symptoms, medication and identify factors related to asthma severity, compare the extent of asthma control in 2001 and 2005, and investigate the development of asthma and degree of asthma control in adolescents and young adults who had reported asthma six years earlier. Methods. The first study was a telephone interview of a representative sample of Swedish asthmatics. In the second study a random sample of 1,136 patients answered two questionnaires. A classification of the asthma severity similar to that in the GINA guidelines was made. In the third study two surveys were performed, in 2001 and in 2005, with a random sample of 1,012 and 224 asthma patients, respectively, and a classification of asthma control similar to the recent GINA guidelines was made. In the fourth study 71 individuals who reported physician-diagnosed asthma in a population-based survey in 1997 and were defined as current asthmatics, were reinvestigated in 2003 with a skin prick test, methacholine challenge test, eucapnic voluntary hyperventilation test and measurement of exhaled nitric oxide. Results. Common situations causing symptoms of asthma were physical exertion and contact with pets. Nocturnal symptoms were frequent. In primary care 35% of the women and 24% of the men were classified as having severe asthma. Female sex, increasing age, not filling the asthma prescription owing to cost, daily smoking, and pollen allergy increased the odds of having severe asthma. In 2001, 37% had achieved asthma control, as compared with 40% in 2005. Uncontrolled asthma was more common in women and smokers. In the 2003 study of adolescents and young adults with asthma six years earlier, the definition of current asthma was fulfilled by 50 of the 71 subjects and one third had achieved asthma control. Conclusions. The majority of the asthmatics reported a large number of symptoms and limitations in their daily living. Many asthma patients in primary care have insufficient asthma control. One reason for lack of control might be undertreatment with inhaled corticosteroids.

APA, Harvard, Vancouver, ISO, and other styles

Byrne, Karen. "Efficacy of yoga practices in treatment of asthma : a systematic review /." Thesis, View the Table of Contents & Abstract, 2006. http://sunzi.lib.hku.hk/hkuto/record/B38030627.

Full text

APA, Harvard, Vancouver, ISO, and other styles

McCants, Kellie M. "Factors affecting treatment regimen adherence in children and adolescents with asthma." Connect to this title online, 2003. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1041866923.

Full text

Abstract:

Thesis (Ph. D.)--Ohio State University, 2004.
Title from first page of PDF file. Document formatted into pages; contains xv, 134 p.; also includes graphics Includes bibliographical references (p. 101-108). Available online via OhioLINK's ETD Center

APA, Harvard, Vancouver, ISO, and other styles

Erasmus, Esther W. "Insights into the psychobiology of personality of individuals living with chronic asthma to inform treatment planning." Pretoria : [s.n.], 2007. http://upetd.up.ac.za/thesis/available/etd-06292007-163159.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Ilicak, Selin. "Children's adjustment to asthma or diabetes and treatment adherence." Thesis, Oxford Brookes University, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.515232.

Full text

Abstract:

This thesis had two main aims. Firstly, to develop separate questionnaires for children with asthma and children with diabetes and their parents, which assess children's adjustment to the illness and treatment adherence. Secondly, to test the hypothesis of an association between children's adjustment and treatment adherence. The essence of asthma and diabetes treatment is self-care and consequently children with asthma or diabetes have to learn to cope with the long-term demands and responsibilities of complying with a strict and complex treatment regimen. It is currently recognized that a major problem in paediatrics is poor treatment adherence, which can result in serious health consequences. This led to a shift in paediatric medicine, from focusing only on the physical treatment of the illness to exploring the psychological impact of the illness and how it affects children's socio-emotional adjustment. However, there is a shortage of adjustment and treatment adherence measures; existing ones have major limitations. Thus, the new questionnaires aimed at assessing both children's adjustment and treatment adherence. Four interlinked studies utilising qualitative and quantitative methods were carried out. Study 1 and study 3 were parallel but separate studies and involved interviewing a group of 15 children with asthma and 15 children with diabetes, their parents and paediatric nurses about the children's experiences and feelings in a range of contexts. The interviews showed that there were commonalities in stressors across children but differences in adjustment and treatment adherence levels. On the basis of these interviews separate questionnaires for children with asthma (study 2) and children with diabetes (study 4) and their parents were developed and administered to a sample of 60 children and their parents. The new questionnaires proved to be reliable and valid and confirmed the hypothesis of a significant relation between children's adjustment and treatment adherence. The development of a new assessment tool involves several steps: This work represents the first steps in developing a new assessment tool. As with any new assessment instrument, further development will be required to examine its validity and reliability.

APA, Harvard, Vancouver, ISO, and other styles

Bolcas, Paige. "Pathogenesis and Treatment Strategies for Difficult-to-Treat Asthma." University of Cincinnati / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1561393922642685.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Williams, Julie M. "Coping with asthma : investigation and intervention using the self-regulation model." Thesis, University of St Andrews, 1995. http://hdl.handle.net/10023/2800.

Full text

Abstract:

The Self-Regulation Model (Leventhal, Nerenz & Steele, 1984) highlights the roles of patients' illness representations, coping, emotional reactions and appraisal of coping in the progression of chronic disease. This thesis incorporates previous literature on adherence, panic-fear and selfmanagement interventions into the model in order to (a) investigate coping with asthma and (b) develop an intervention aimed at improving asthmatic control. New measures of asthmatic control and illness representations of the consequences of having asthma were developed in order to operationalise the model. A cross-sectional study investigated factors influencing asthmatic control in a sample of 35 adult asthma sufferers recruited through a single general practice. Coping was poor, adherence being low and less than 50% of participants reporting current Peak Flow monitoring or medical contact during the previous 12 months. Good coping appeared to be a response to poor asthmatic control, rather than prophylactic. Good asthmatic control was associated with low perceived consequences, recent medical contact, moderate panic-fear and low general avoidance coping. These results imply that asthmatic control may be improved by encouraging sufferers to maintain regular contact with outpatient services and to implement prophylactic coping. Since epidemiological and clinical evidence suggested asthmatic control to be poor in young adults, an intervention was developed to improve asthmatic control in this group by modifying illness representations, coping and panic-fear. The intervention was evaluated in a randomised controlled study of 50 student asthma sufferers identified initially through an epidemiological screening of 2,979 students. It led to increased Preventer medication use and Peak Flow monitoring and decreased distress over the condition. However, the coping process changed and asthmatic control improved even in the control group, perhaps because self-monitoring of asthmatic control for the study constituted a change in coping. This unanticipated result was entirely compatible with the Self-Regulation Model. The thesis dearly demonstrates value of the Self-Regulation Model in understanding asthma self-management and developing clinical interventions.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Asthma – Treatment"

NATO Advanced Study Institute on Asthma Treatment - a Multidisciplinary Approach (1991 Erice, Italy). Asthma treatment. New York: Plenum Press, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Olivieri, D., P. J. Barnes, S. S. Hurd, and G. C. Folco, eds. Asthma Treatment. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3446-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

V, Patterson Alina, and Yeager Pauline N, eds. Asthma: Etiology, pathogenesis & treatment. New York: Nova Science Publishers, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Heaney, Liam G., and Andrew Menzies-Gow. Difficult asthma. New Delhi: Jaypee Brothers Medical Publishers (P) LTD., 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Marie-Josée, Caron, ed. Oublier son asthme. Montréal: Éditions de l'Homme, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Mansfield, John. Asthma epidemic. London: Thorsons, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Asthma: Physiology, immunopharmacology and treatment. London: Academic, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Romain, Pauwels, and O'Byrne Paul M. 1951-, eds. Beta₂-agonists in asthma treatment. New York: Dekker, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

1946-, Martin Richard J., ed. Nocturnal asthma: Mechanisms and treatment. Mount Kisco, NY: Futura Pub., 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

All about asthma. Ringwood, Vic: Viking, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Asthma – Treatment"

Tattersfield, A. E. "Asthma Management." In Asthma Treatment, 193–206. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3446-4_18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Bertrand, Pablo, and Andrea Beckhaus Faccin. "Asthma: Treatment." In Pediatric Respiratory Diseases, 415–28. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-26961-6_42.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Tattersfield, Anne E., and Martin W. McNicol. "Asthma." In Treatment in Clinical Medicine, 23–49. London: Springer London, 1987. http://dx.doi.org/10.1007/978-1-4471-3132-8_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Jeffery, Peter K. "Histopathology of Bronchial Asthma and the Effects of Treatment." In Asthma Treatment, 1–7. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3446-4_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Del Prete, Gianfranco. "Synthesis and Regulation of IgE in Asthma." In Asthma Treatment, 117–29. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3446-4_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Genovese, Arturo, Giuseppe Spadaro, Anna Ciccarelli, Amato de Paulis, Raffaele Cirillo, and Gianni Marone. "Modulation of Mediator Release From Human FcεRI+ Cells." In Asthma Treatment, 131–44. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3446-4_11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Bianco, Sebastiano, Mariella Robuschi, Adriano Vaghi, Gabriella Gambaro, Stefano Spagnotto, Maria Grazia Pieroni, Rosa Metella Refini, and Piersante Sestini. "Osmotic and Ionic Factors in Bronchial Responsiveness." In Asthma Treatment, 145–54. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3446-4_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Brusasco, Vito, Emanuele Crimi, and Giovanni A. Rossi. "Airway Responsiveness, Late-Phase Response, and Inflammation in Allergic Asthma." In Asthma Treatment, 155–60. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3446-4_13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Rennard, Stephen I., Kathleen A. Rickard, Debra J. Romberger, Joe D. Beckmann, Oliviero Sacco, Masashi Kawamoto, and John R. Spurzem. "Injury and Repair of the Airway Epithelium in Asthma." In Asthma Treatment, 161–70. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3446-4_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Rennard, Stephen I., and Kathleen Rickard. "Bronchoalveolar Lavage: Its Application in Asthma." In Asthma Treatment, 171–82. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3446-4_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Asthma – Treatment"

Baan, Esmé J., Leila Karimi, Astrid Heeremans, Guy G. Brusselle, Miriam Sturkenboom, Hettie M. Janssens, Lies Lahousse, and Katia M. Verhamme. "Asthma treatment in real life." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa4207.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Jones, Matthew, Emily Heiden, Jessica Gates, David Lodge, Ruth De Vos, Rachel Harvey, Scott Elliott, Thomas Brown, Anoop Chauhan, and Hitasha Rupani. "Adherence to steroid treatment in asthma." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa4183.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Puig Sánchez, Francisco Guillermo, Auxiliadora Romero Falcón, Juan Francisco Medina Gallardo, Javier Castilla Guerra, Laura Carrasco Hernández, and Francisco Javier Alvarez Gutiérrez. "Treatment compliance in patients with Asthma, COPD and Mixed Asthma-COPD." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa4187.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Havlucu, Yavuz, Arzu Yorgancioglu, Fikret Kurhan, Tugba Goktalay, Aysin Sakar Coskun, and Pinar Celik. "Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa1091.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Maazaoui, Sarra, Besma Hamdi, Khouloud Abdelmoulah, Alaa Akkad, Baraa Bdira, Jamel Ammar, Anissa Berraies, and Agnes Hamzaoui. "Is antibiotic treatment during asthma exacerbation necessary?" In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa4030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Erdogan, Tuba, Ozge Ozturk Aktas, Ebru Çelebioglu, Gül Karakaya, and Ali Fuat Kalyoncu. "Codeine for treatment of cough variant asthma." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa3369.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Parchami, Ghazaee, Nataliia Voloshyna, and Murtaza Hameed. "NOVEL AGENTS FOR THE TREATMENT OF ASTHMA." In ADVANCED DISCOVERIES OF MODERN SCIENCE: EXPERIENCE, APPROACHES AND INNOVATIONS. European Scientific Platform, 2021. http://dx.doi.org/10.36074/logos-09.04.2021.v2.35.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Do, Quan T., Alexa K. Doig, Tran C. Son, and Jamil M. Chaudri. "Personalized Prediction of Asthma Severity and Asthma Attack for a Personalized Treatment Regimen." In 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2018. http://dx.doi.org/10.1109/embc.2018.8513281.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Szefler, Stanley, Jenya Antonova, Benjamin Trzaskoma, Benjamin Ortiz, Brandee Paknis, Ahmar Iqbal, and Stanley Goldstein. "Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa587.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Winsa Lindmark, Sofia, Ludwig Sandström, Johanna Selberg, Linnea Hedman, Helena Backman, Eva Rönmark, and Caroline Stridsman. "Treatment adherence among adults with asthma– A report from the OLIN asthma cohort." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.5169.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Asthma – Treatment"

Chen, Alex, and José Escarce. Family Structure and the Treatment of Childhood Asthma. Cambridge, MA: National Bureau of Economic Research, October 2007. http://dx.doi.org/10.3386/w13461.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Lin, Sandra Y., Antoine Azar, Catalina Suarez-Cuervo, Gregory B. Diette, Emily Brigham, Jessica Rice, Murugappan Ramanathan, Jr., Jessica Gayleard, and Karen A. Robinson. The Role of Immunotherapy in the Treatment of Asthma. Agency for Healthcare Research and Quality, 2017. http://dx.doi.org/10.23970/ahrqepccer196.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Rojas Smith, Lucia, Megan L. Clayton, Carol Woodell, and Carol Mansfield. The Role of Patient Navigators in Improving Caregiver Management of Childhood Asthma. RTI Press, April 2017. http://dx.doi.org/10.3768/rtipress.2017.rr.0030.1704.

Full text

Abstract:

Childhood asthma is a significant public health problem in the United States. Barriers to effective asthma management in children include the need for caregivers to identify and manage diverse environmental triggers and promote appropriate use of preventive asthma medications. Although health care providers may introduce asthma treatments and care plans, many providers lack the time and capacity to educate caregivers about asthma in an ongoing, sustained manner. To help address these complexities of asthma care, many providers and caregivers rely on patient navigators (defined as persons who provide patients with a particular set of services and who address barriers to care) (Dohan & Schrag, 2005). Despite growing interest in their value for chronic disease management, researchers and providers know little about how or what benefits patient navigators can provide to caregivers in managing asthma in children. To explore this issue, we conducted a mixed-method evaluation involving focus groups and a survey with caregivers of children with moderate-to-severe asthma who were enrolled in the Merck Childhood Asthma Network Initiative (MCAN). Findings suggest that patient navigators may support children’s asthma management by providing individualized treatment plans and hands-on practice, improving caregivers’ understanding of environmental triggers and their mitigation, and giving clear, accessible instructions for proper medication management. Study results may help to clarify and further develop the role of patient navigators for the effective management of asthma in children.

APA, Harvard, Vancouver, ISO, and other styles

Heng, Zhaorui, Han Jing, Wangjian Xing, Hanze Lu, Zhang Qing, Wanjing Xuan, and Linjiang Tao. Safety and efficacy of acupuncture for treatment of cough variant asthma: a systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2021. http://dx.doi.org/10.37766/inplasy2021.1.0105.

Full text

APA, Harvard, Vancouver, ISO, and other styles

XU, QIANWEN, and QIKUN HUANG. Meta-analysis of the clinical efficacy of Bifidobacterium trivium in the treatment of asthma in children. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Shang, GuangYuan, ShuangZhu Lin, GuiLin Wang, MeiJia Qian, XiaoChun Feng, and Kai Jiang. A meta-analysis of the efficacy and safety of Chinese herbal compound in the treatment of children with cough variant asthma. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2021. http://dx.doi.org/10.37766/inplasy2021.1.0087.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Guo, Lei, Lie Wang, Zhongtian Wang, Lina Wei, Lizhong Ding, Yibu Kong, Zhimei Liu, Ye Tian, Fushuang Yang, and Liping Sun. Efficacy and safety of cupping combined with Chinese herbal medicine in the treatment of asthma: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2021. http://dx.doi.org/10.37766/inplasy2021.9.0089.

Full text

APA, Harvard, Vancouver, ISO, and other styles

MO, Jingwen, Yiyi Zhang, Lingling Han, and Huiling Tang. Efficacy of combination of Shegan Mahuang Decoction and Montelukast Sodium in the Treatment of Cough Variant Asthma: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2021. http://dx.doi.org/10.37766/inplasy2021.12.0107.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Mao, Hui, YueHui Wei, Huimin Su, and Xun Li. Pediatric Tui Na for cough in children: A protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2022. http://dx.doi.org/10.37766/inplasy2022.2.0076.

Full text

Abstract:

Review question / Objective: The aim of this systematic review is to evaluate the effectiveness and safety of pediatric Tui Na in the treatment of cough in children under seven years of age. Condition being studied: Cough is essentially a protective reflex of respiratory tract to various stimuli, typically in order to clear the lung airways of fluids, mucus, or other material. Cough not only has a negative impact on children’s daily activities and sleep, but is associated with parental stress and worries. Pediatric Tui Na, a therapeutic massage based on the Chinese traditional theory of Yin and Yang, Qi and blood, acupoints and meridians, enjoys a long history and has been widely applied to the treatment of common diseases like fever, diarrhea, cough and asthma. This study aims to evaluate the effectiveness and safety of pediatric Tui Na in the treatment of cough in children.

APA, Harvard, Vancouver, ISO, and other styles

Hong, Zheng, Ying Liu, Hanyu Fang, Bang Yu, and Hongchun Zhang. Effectiveness and safety of Suhuang Zhike Capsule in combination with budesonide in the treatment of cough variant asthma in adults: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0082.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!